US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

LB Pharmaceuticals

37.77

+3.169.13%

Volume:229.03K

Turnover:8.53M

Market Cap:1.22B

PE:-12.64

High:38.50

Open:35.01

Low:35.01

Close:34.61

52wk High:50.16

52wk Low:14.32

Shares:32.26M

Float Shares:21.62M

Volume Ratio:1.16

T/O Rate:1.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.9880

EPS(LYR):-3.1329

ROE:-50.00%

ROA:-29.98%

PB:3.67

PE(LYR):-12.06

Loading ...

Overview Company News Filings

Lb Pharmaceuticals Inc : Canaccord Genuity Initiates Coverage with Buy Rating; Target Price $65

THOMSON REUTERS

Canaccord Genuity Initiates LB Pharmaceuticals at Buy With $65 Price Target

MT Newswires Live

LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment

Guggenheim stats LB Pharmaceuticals at Buy, calls best idea

LB Pharmaceuticals Price Target Cut to $35.00/Share from $37.00 by Roth Capital

LB Pharmaceuticals downgraded to Neutral from Buy at Roth Capital

Needham Initiates LB Pharmaceuticals at Buy With $68 Price Target

MT Newswires Live

LB Pharmaceuticals Initiated at Buy by Needham

LB Pharmaceuticals initiated with a Buy at Needham

Analyst Initiates Buy Rating on LB-102 for De-Risked Antipsychotic Profile, Multi-Indication Potential and Strong Long-Term Revenue Outlook

Lb Pharmaceuticals Inc : Needham Initiates Coverage with Buy Rating; Target Price $68

THOMSON REUTERS

Lb Pharmaceuticals Inc Files for Mixed Shelf; Size not Disclosed - SEC Filing

THOMSON REUTERS

LB Pharmaceuticals’ Chief Medical Officer Susan Gani Kozauer Files Initial Beneficial Ownership Statement (Form 3)

Lb Pharmaceuticals Appoints Susan G. Kozauer, M.d. as Chief Medical Officer

THOMSON REUTERS

Press Release: LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer

LB Pharmaceuticals CFO Joseph M. Miller Files Initial Beneficial Ownership Statement

LB Pharmaceuticals to Participate in Upcoming September Investor Events

LB Pharmaceuticals Names Joseph Miller CFO

MT Newswires Live

Lb Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer

THOMSON REUTERS

Press Release: LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LBRX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LBRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","market":"US","secType":"STK","nameCN":"LB Pharmaceuticals","latestPrice":37.77,"timestamp":1791563312962,"preClose":34.61,"halted":0,"volume":229027,"delay":0,"changeRate":0.09130309159202553,"floatShares":21621800,"shares":32259175,"eps":-2.988,"marketStatus":"Trading","change":3.16,"latestTime":"10-09 12:28:45 EDT","open":35.01,"high":38.5,"low":35.01,"amount":8527777.745978,"amplitude":0.100838,"askPrice":37.92,"askSize":191,"bidPrice":37.77,"bidSize":700,"shortable":3,"etf":0,"ttmEps":-2.988,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791576000000},"marketStatusCode":2,"adr":0,"listingDate":1757563200000,"exchange":"NASDAQ","adjPreClose":34.61,"preHourTrading":{"tag":"盘前","latestPrice":35.99,"preClose":34.61,"latestTime":"05:36 EDT","volume":87,"amount":3131.13,"timestamp":1791538564916,"change":1.38,"changeRate":0.039873,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.61,"preClose":34.61,"latestTime":"19:30 EDT","volume":3570,"amount":123557.7,"timestamp":1791502204109,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.164878,"impliedVol":0.7051,"impliedVolPercentile":0.5484},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LBRX\",,,,,undefined,":{"symbol":"LBRX","floatShares":21621800,"roa":"-29.98%","roe":"-50.00%","lyrEps":-3.132945,"volumeRatio":1.164878,"shares":32259175,"dividePrice":0,"high":38.5,"amplitude":0.100838,"preClose":34.61,"low":35.01,"week52Low":14.3166,"pbRate":"3.67","week52High":50.16,"institutionHeld":0,"latestPrice":37.77,"committee":0.571268,"eps":-2.988,"divideRate":0,"volume":229027,"delay":0,"ttmEps":-2.988,"open":35.01,"prevYearClose":22.26,"prevWeekClose":36.99,"prevMonthClose":38.38,"prevQuarterClose":38.38,"fiveDayClose":36.99,"twentyDayClose":44.63,"sixtyDayClose":30.59},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LBRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"LBRX","fiscalQuarterEnding":"2026/06","expectedEps":-0.84,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-1.71},{"market":"US","date":"2026-05-12","symbol":"LBRX","fiscalQuarterEnding":"2026/03","expectedEps":-0.75,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-0.67},{"market":"US","date":"2026-03-26","symbol":"LBRX","fiscalQuarterEnding":"2025/12","expectedEps":-0.45,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774497600000,"reportTimeType":"post","actualEps":-0.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LBRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LBRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3636,"buy":0.5455,"hold":0.0909,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5455,"analysts":11,"updateTime":1791259200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LBRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LBRX","date":"2026-10-08","current":-12.640562,"percent":0.851301,"low":-37.407457,"twenty":-31.662895,"median":-23.624208,"eighty":-15.964499,"high":-0.410019,"avg":-23.348487,"sd":7.611903,"marketCap":1101973418},"quantilePoints":[{"date":"2025-09-12","current":-13.187639,"twenty":-10.632115,"median":-6.798829,"eighty":-2.965543,"marketCap":388099031},{"date":"2025-09-19","current":-12.217088,"twenty":-12.798201,"median":-12.438246,"eighty":-12.070666,"marketCap":359536683},{"date":"2025-09-26","current":-11.40109,"twenty":-12.682283,"median":-12.163705,"eighty":-11.408716,"marketCap":335522685},{"date":"2025-10-03","current":-11.790024,"twenty":-12.394014,"median":-12.03406,"eighty":-11.475827,"marketCap":346968609},{"date":"2025-10-10","current":-11.927294,"twenty":-12.217088,"median":-11.973051,"eighty":-11.471251,"marketCap":351008347},{"date":"2025-10-17","current":-12.506882,"twenty":-12.401641,"median":-12.018808,"eighty":-11.491079,"marketCap":368065019},{"date":"2025-10-24","current":-12.079817,"twenty":-12.247593,"median":-12.026434,"eighty":-11.561239,"marketCap":355496945},{"date":"2025-10-31","current":-12.415368,"twenty":-12.43367,"median":-12.041687,"eighty":-11.652753,"marketCap":365371860},{"date":"2025-11-07","current":-18.511527,"twenty":-12.493155,"median":-12.14464,"eighty":-11.774771,"marketCap":348090759},{"date":"2025-11-14","current":-20.046619,"twenty":-12.715838,"median":-12.201836,"eighty":-11.777822,"marketCap":376956619},{"date":"2025-11-21","current":-21.244034,"twenty":-16.587413,"median":-12.217088,"eighty":-11.811377,"marketCap":399472820},{"date":"2025-11-28","current":-23.934856,"twenty":-18.511527,"median":-12.278098,"eighty":-11.89679,"marketCap":450071024},{"date":"2025-12-05","current":-25.899155,"twenty":-20.625145,"median":-12.354359,"eighty":-11.912042,"marketCap":487007713},{"date":"2025-12-12","current":-27.217658,"twenty":-21.714928,"median":-12.472564,"eighty":-11.927294,"marketCap":511800833},{"date":"2025-12-19","current":-26.50459,"twenty":-23.934856,"median":-12.598395,"eighty":-11.934921,"marketCap":498392309},{"date":"2025-12-26","current":-29.599034,"twenty":-25.317938,"median":-12.735666,"eighty":-11.971526,"marketCap":556580244},{"date":"2026-01-02","current":-29.948841,"twenty":-26.033696,"median":-12.811928,"eighty":-12.003556,"marketCap":563158010},{"date":"2026-01-09","current":-27.984542,"twenty":-26.736001,"median":-17.717835,"eighty":-12.027959,"marketCap":526221321},{"date":"2026-01-16","current":-28.76488,"twenty":-26.943194,"median":-18.511527,"eighty":-12.038636,"marketCap":540894800},{"date":"2026-01-23","current":-31.724783,"twenty":-27.597063,"median":-20.046619,"eighty":-12.056939,"marketCap":596552825},{"date":"2026-01-30","current":-28.482344,"twenty":-28.30475,"median":-20.93459,"eighty":-12.092019,"marketCap":535581989},{"date":"2026-02-06","current":-32.101498,"twenty":-28.673392,"median":-21.418938,"eighty":-12.137776,"marketCap":603636573},{"date":"2026-02-13","current":-32.760749,"twenty":-28.899421,"median":-22.367452,"eighty":-12.188109,"marketCap":616033133},{"date":"2026-02-20","current":-32.558938,"twenty":-29.179266,"median":-23.692682,"eighty":-12.201836,"marketCap":612238268},{"date":"2026-02-27","current":-32.5993,"twenty":-29.599034,"median":-24.876643,"eighty":-12.203361,"marketCap":612997241},{"date":"2026-03-06","current":-31.684421,"twenty":-30.30403,"median":-25.616619,"eighty":-12.210987,"marketCap":595793852},{"date":"2026-03-13","current":-33.554542,"twenty":-31.627914,"median":-25.899155,"eighty":-12.217088,"marketCap":630959603},{"date":"2026-03-20","current":-32.276402,"twenty":-31.988483,"median":-26.370049,"eighty":-12.224714,"marketCap":606925456},{"date":"2026-03-27","current":-24.621582,"twenty":-31.988483,"median":-26.625677,"eighty":-12.26437,"marketCap":620586972},{"date":"2026-04-02","current":-24.902627,"twenty":-31.966957,"median":-26.235508,"eighty":-12.300976,"marketCap":627670720},{"date":"2026-04-10","current":-26.388153,"twenty":-31.886233,"median":-26.156251,"eighty":-12.33148,"marketCap":665113391},{"date":"2026-04-17","current":-28.385582,"twenty":-31.84587,"median":-26.235508,"eighty":-12.354359,"marketCap":715458604},{"date":"2026-04-24","current":-35.011617,"twenty":-31.993865,"median":-26.565134,"eighty":-12.415368,"marketCap":882467800},{"date":"2026-05-01","current":-36.076352,"twenty":-32.168769,"median":-26.669198,"eighty":-12.438246,"marketCap":909304449},{"date":"2026-05-08","current":-36.38353,"twenty":-32.30331,"median":-26.814034,"eighty":-12.506882,"marketCap":917046871},{"date":"2026-05-15","current":-23.123601,"twenty":-32.316764,"median":-26.760218,"eighty":-12.583143,"marketCap":900733639},{"date":"2026-05-22","current":-20.613207,"twenty":-32.30331,"median":-26.667619,"eighty":-12.598395,"marketCap":802946256},{"date":"2026-05-29","current":-20.2672,"twenty":-32.30331,"median":-26.565134,"eighty":-12.6289,"marketCap":789468229},{"date":"2026-06-05","current":-21.275774,"twenty":-32.281784,"median":-26.235508,"eighty":-12.715838,"marketCap":828755242},{"date":"2026-06-12","current":-21.010748,"twenty":-32.254875,"median":-25.973152,"eighty":-12.741767,"marketCap":818431648},{"date":"2026-06-18","current":-22.122388,"twenty":-32.201059,"median":-25.758446,"eighty":-12.784474,"marketCap":861733392},{"date":"2026-06-26","current":-22.821765,"twenty":-32.168769,"median":-25.603165,"eighty":-13.037355,"marketCap":888976212},{"date":"2026-07-02","current":-23.476971,"twenty":-32.141861,"median":-25.394457,"eighty":-14.887526,"marketCap":914498432},{"date":"2026-07-10","current":-24.838915,"twenty":-32.079972,"median":-25.197689,"eighty":-17.661739,"marketCap":967550238},{"date":"2026-07-17","current":-22.519929,"twenty":-32.026155,"median":-24.876643,"eighty":-18.127213,"marketCap":877218784},{"date":"2026-07-24","current":-25.486758,"twenty":-31.993865,"median":-24.857779,"eighty":-18.396949,"marketCap":992785692},{"date":"2026-07-31","current":-30.110006,"twenty":-31.988483,"median":-25.029051,"eighty":-18.623718,"marketCap":1172875066},{"date":"2026-08-07","current":-35.46944,"twenty":-32.036919,"median":-25.243817,"eighty":-19.236335,"marketCap":1381641093},{"date":"2026-08-14","current":-16.667021,"twenty":-32.036919,"median":-25.197689,"eighty":-18.062763,"marketCap":1428113677},{"date":"2026-08-21","current":-17.781418,"twenty":-31.993865,"median":-24.876643,"eighty":-17.822455,"marketCap":1523600835},{"date":"2026-08-28","current":-18.029899,"twenty":-31.988483,"median":-24.686825,"eighty":-17.939919,"marketCap":1544891890},{"date":"2026-09-04","current":-17.890599,"twenty":-31.950812,"median":-24.595973,"eighty":-17.81229,"marketCap":1532955996},{"date":"2026-09-11","current":-17.412462,"twenty":-31.886233,"median":-24.257328,"eighty":-17.792713,"marketCap":1491986843},{"date":"2026-09-18","current":-15.865106,"twenty":-31.84587,"median":-23.934856,"eighty":-17.412462,"marketCap":1359401634},{"date":"2026-09-25","current":-14.231158,"twenty":-31.724783,"median":-23.892916,"eighty":-16.881618,"marketCap":1219396815},{"date":"2026-10-02","current":-14.035386,"twenty":-31.684421,"median":-23.764083,"eighty":-16.185119,"marketCap":1202622044},{"date":"2026-10-08","current":-12.860751,"twenty":-31.662895,"median":-23.624208,"eighty":-15.964499,"marketCap":1101973418}],"updateTime":1791563325384},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LBRX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2674085408","title":"Lb Pharmaceuticals Inc : Canaccord Genuity Initiates Coverage with Buy Rating; Target Price $65","url":"https://stock-news.laohu8.com/highlight/detail?id=2674085408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674085408?lang=en_us&edition=fundamental","pubTime":"2026-10-09 21:01","pubTimestamp":1791550860,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261009:nFWN45V1F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674799837","title":"Canaccord Genuity Initiates LB Pharmaceuticals at Buy With $65 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2674799837","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674799837?lang=en_us&edition=fundamental","pubTime":"2026-10-09 17:20","pubTimestamp":1791537611,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals (LBRX) has an average rating of buy and mean price target of $58.36, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673566840","title":"LB Pharmaceuticals to Host In-Person and Virtual R&D Day on October 27, 2026: Advancing LB‑102 with a Focus on Schizophrenia Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2673566840","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673566840?lang=en_us&edition=fundamental","pubTime":"2026-10-06 20:00","pubTimestamp":1791288000,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct.  06, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-im","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/06/3375433/0/en/lb-pharmaceuticals-to-host-in-person-and-virtual-r-d-day-on-october-27-2026-advancing-lb-102-with-a-focus-on-schizophrenia-treatment.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357125470.USD","LU2249611893.SGD","CFO","CCO","LU2506951792.HKD","CEO","LU0823414478.USD","LU0823414551.USD","LBRX","BK4009","BK4007","LU2294711713.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084940","title":"Guggenheim stats LB Pharmaceuticals at Buy, calls best idea","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084940","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084940?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:20","pubTimestamp":1791231619,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Delma Caiati initiated coverage of LB Pharmaceuticals (LBRX) with a Buy rating and $80 price target The analyst named LB a best ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/guggenheim-stats-lb-pharmaceuticals-at-buy-calls-best-idea-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/guggenheim-stats-lb-pharmaceuticals-at-buy-calls-best-idea-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673086790","title":"LB Pharmaceuticals Price Target Cut to $35.00/Share from $37.00 by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673086790","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673086790?lang=en_us&edition=fundamental","pubTime":"2026-10-06 01:19","pubTimestamp":1791220740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673025707","title":"LB Pharmaceuticals downgraded to Neutral from Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2673025707","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673025707?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:55","pubTimestamp":1791204929,"startTime":"0","endTime":"0","summary":"Roth Capital downgraded LB Pharmaceuticals (LBRX) to Neutral from Buy with a price target of $35, down from $37. Faster development and competitive...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-downgraded-to-neutral-from-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-downgraded-to-neutral-from-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715536","title":"Needham Initiates LB Pharmaceuticals at Buy With $68 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715536","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715536?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:48","pubTimestamp":1790934506,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals (LBRX)has an average rating of buy and mean price target of $58.56, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672132107","title":"LB Pharmaceuticals Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2672132107","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672132107?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:29","pubTimestamp":1790933340,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LBRX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672713863","title":"LB Pharmaceuticals initiated with a Buy at Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2672713863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672713863?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:55","pubTimestamp":1790931308,"startTime":"0","endTime":"0","summary":"Needham initiated coverage of LB Pharmaceuticals (LBRX) with a Buy rating and $68 price target The company’s LB-102 is an improved version of amisu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lb-pharmaceuticals-initiated-with-a-buy-at-needham-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718168","title":"Analyst Initiates Buy Rating on LB-102 for De-Risked Antipsychotic Profile, Multi-Indication Potential and Strong Long-Term Revenue Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718168","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672718168?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:35","pubTimestamp":1790930121,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals, Inc. (LBRX) has received a new Buy rating, initiated by Needham analyst, Ami Fadia. Ami Fadia has given his Buy rating due to a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-rating-on-lb-102-for-de-risked-antipsychotic-profile-multi-indication-potential-and-strong-long-term-revenue-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/analyst-initiates-buy-rating-on-lb-102-for-de-risked-antipsychotic-profile-multi-indication-potential-and-strong-long-term-revenue-outlook-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672718328","title":"Lb Pharmaceuticals Inc : Needham Initiates Coverage with Buy Rating; Target Price $68","url":"https://stock-news.laohu8.com/highlight/detail?id=2672718328","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672718328?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:25","pubTimestamp":1790929528,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nFWN45O0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672649167","title":"Lb Pharmaceuticals Inc Files for Mixed Shelf; Size not Disclosed - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2672649167","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672649167?lang=en_us&edition=fundamental","pubTime":"2026-10-02 04:06","pubTimestamp":1790885213,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nFWN45N151:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670418185","title":"LB Pharmaceuticals’ Chief Medical Officer Susan Gani Kozauer Files Initial Beneficial Ownership Statement (Form 3)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670418185","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670418185?lang=en_us&edition=fundamental","pubTime":"2026-09-25 04:27","pubTimestamp":1790281648,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals’ Chief Medical Officer Susan Gani Kozauer files initial beneficial ownership statement (Form 3)LB Pharmaceuticals filed a Form 3 naming Susan Gani Kozauer as chief medical officer, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL9n9GmP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667644444","title":"Lb Pharmaceuticals Appoints Susan G. Kozauer, M.d. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667644444","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667644444?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473608,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nTUA6SQT0T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667176644","title":"Press Release: LB Pharmaceuticals Appoints Susan G. Kozauer, M.D. as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667176644","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667176644?lang=en_us&edition=fundamental","pubTime":"2026-09-15 20:00","pubTimestamp":1789473600,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (\"LB Pharmaceuticals\" or the \"Company\") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-im","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695896","title":"LB Pharmaceuticals CFO Joseph M. Miller Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695896","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695896?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:16","pubTimestamp":1789416965,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals CFO Joseph M. Miller files initial beneficial ownership statementLB Pharmaceuticals named Joseph M. Miller as chief financial officer in an initial Form 3 insider filing dated 09/02","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL7T2zSC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664801118","title":"LB Pharmaceuticals to Participate in Upcoming September Investor Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2664801118","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664801118?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:05","pubTimestamp":1788465900,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  03, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-i","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/03/3356251/0/en/lb-pharmaceuticals-to-participate-in-upcoming-september-investor-events.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LBRX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874706","title":"LB Pharmaceuticals Names Joseph Miller CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874706","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874706?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:38","pubTimestamp":1788439125,"startTime":"0","endTime":"0","summary":"LB Pharmaceuticals (LBRX) said Thursday it named Joseph Miller its chief financial officer.Miller was previously Aurinia Pharmaceuticals' (AUPH) CFO, LB Pharmaceuticals said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CFO","BK4149","AUPH","LBRX","BK4139","MLR","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871485","title":"Lb Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871485","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871485?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436803,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nTUA9T67BV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","LBRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664871172","title":"Press Release: LB Pharmaceuticals Appoints Joseph Miller as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664871172","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664871172?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:00","pubTimestamp":1788436800,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (\"LB Pharmaceuticals\" or the \"Company\") (Nasdaq: LBRX), a neuromedicines company dedicated to developing and commercializing high-im","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","MLR","BK4149","LBRX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":83,"code":"91000000","status":"200"}]}}